Based on several studies in the field, the amount of CD64 expression during the first 24 hours of suspected clinical infection can allow clinicians to discontinue unnecessary antimicrobial treatments with no need to wait for confirmation by microbiological testing90–92. This evidence concerns the gene FCGR1A and infection.